| Company type | Private ownership |
|---|---|
| Industry | Pharmaceutical |
| Founded | 1971 (1971) |
| Headquarters | Taizhou,China |
Area served | Central/Southeast Asia |
Key people | Xu Jingren, Founder/President Xu Haoyu, Chairman/Interim CEO |
| Products | Antibiotics, Chemotherapy drugs, herbal remedies |
| Revenue | |
| Total assets | |
Number of employees | 13,000 (2016)[2] |
| Website | yangzijiang |
Yangtze River Pharmaceutical Group (Chinese:扬子江药业集团, YRPG) is a Chinesemultinationalpharmaceutical corporation headquartered inTaizhou, Jiangsu Province in thePeople's Republic of China, and with its research headquarters inShanghai.[3] It is one of theAsia's largest pharmaceutical companies by revenues, and was listed in 2014 as being China's second largest pharmaceutical manufacturer, and leading company for technological and entrepreneurial innovation.[4]
Founded in 1971, the Yangtze River Pharmaceutical Group started as a local firm providing drugstores and hospitals withvitamin supplements andpain medication.[5] In a prime location between the major cities ofShanghai,Suzhou, andHangzhou, the YRPG quickly expanded its business profile. The group has experienced significant growth in the past decade, having quadrupled their net income between 2003 and 2010.[1] In the fiscal year 2014, board shareholders received a record 560% return on investment, and company assets rapidly expanded.[1]
With the company's quickly rising profile, founderXu Jingren and his extended family—who jointly own a controlling stake in the corporation—have made a number of significant business acquisitions.[6] Collectively, they are believed to be worth up toUSD$7.5 billion. In addition to his role as president and primary shareholder of YRPG,Xu Jingren is a member of theNational People's Congress[7] and serves as an honorary minister in theMinistry of Health. He has been recognized as a leading proponent of industrial modernization, worker's rights, and governmental reform within theChinese Communist Party.[8]